AQUA PHARMA GROUP AS

2624 LILLEHAMMER

Finances

Return on Equity

−21,42 %

Current Ratio

4,82

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	317 767 000	356 178 000	380 531 000	140 691 000
Net Income	−63 949 000	−15 192 000	−5 876 000	25 012 000
Total Assets	338 299 000	423 777 000	507 664 000	526 893 000
Total Equity	298 532 000	388 450 000	442 600 000	445 485 000

Income (NOK)	2022	2021	2020	2019
Revenue	317 767 000	356 178 000	380 531 000	140 691 000
Expenditure	361 584 000	361 051 000	363 847 000	105 392 000
Operating Profit	−43 817 000	−4 873 000	16 684 000	35 298 000
Financial Income	9 108 000	13 157 000	5 876 000	10 086 000
Financial Costs	13 297 000	8 269 000	15 737 000	9 027 000
Financial Balance	−4 189 000	4 888 000	−9 861 000	1 059 000
Earnings Before Tax	−48 005 000	15 000	6 823 000	36 357 000
Tax	15 944 000	15 207 000	12 698 000	11 346 000
Net Income	−63 949 000	−15 192 000	−5 876 000	25 012 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	146 663 000	214 648 000	290 373 000	344 188 000
Total Current Assets	191 636 000	209 129 000	217 291 000	182 705 000
Total Assets	338 299 000	423 777 000	507 664 000	526 893 000
Total Retained Equity	13 536 000	−745 000	21 702 000	24 587 000
Total Equity	298 532 000	388 450 000	442 600 000	445 485 000
Total Long-Term Debt	0	1 326 000	11 535 000	22 321 000
Total Current Debt	39 767 000	34 002 000	53 528 000	59 087 000
Total Equity and Debt	338 299 000	423 777 000	507 664 000	526 893 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	306 660 000	351 584 000	369 523 000	132 201 000
Other Income	11 107 000	4 594 000	11 008 000	8 490 000
Revenue	317 767 000	356 178 000	380 531 000	140 691 000
Cost of Goods Sold	171 996 000	184 047 000	195 390 000	64 024 000
Salary Costs	45 367 000	34 948 000	34 343 000	6 538 000
Depreciation	72 737 000	83 254 000	86 571 000	22 257 000
Impairment	0	0	0	0
Expenditure	361 584 000	361 051 000	363 847 000	105 392 000
Operating Profit	−43 817 000	−4 873 000	16 684 000	35 298 000
Financial Income	9 108 000	13 157 000	5 876 000	10 086 000
Financial Costs	13 297 000	8 269 000	15 737 000	9 027 000
Financial Balance	−4 189 000	4 888 000	−9 861 000	1 059 000
Dividends	30 000 000	30 000 000	0	0
Net Income	−63 949 000	−15 192 000	−5 876 000	25 012 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	77 221 000	121 250 000	164 748 000	209 068 000
Total Intangible Assets	83 143 000	128 545 000	172 104 000	216 843 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	36 336 000	49 081 000	76 013 000	71 043 000
Fixtures	7 469 000	10 040 000	5 223 000	7 111 000
Total Tangible Assets	63 494 000	82 031 000	117 219 000	126 931 000
Total Fiancial Fixed Assets	26 000	4 072 000	1 049 000	414 000
Total Fixed Assets	146 663 000	214 648 000	290 373 000	344 188 000
Stock	19 347 000	19 497 000	23 379 000	20 820 000
Total Investments	0	0	0	0
Cash, Bank	117 352 000	151 174 000	145 720 000	98 702 000
Total Current Assets	191 636 000	209 129 000	217 291 000	182 705 000
Total Assets	338 299 000	423 777 000	507 664 000	526 893 000
Total Equity	298 532 000	388 450 000	442 600 000	445 485 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	1 326 000	11 535 000	22 321 000
Creditors	20 009 000	9 454 000	14 079 000	22 767 000
Unpaid Taxes	12 103 000	14 750 000	16 033 000	11 297 000
Dividends	30 000 000	30 000 000	0	0
Other Current Debt	7 655 000	9 228 000	10 998 000	20 949 000
Total Current Debt	39 767 000	34 002 000	53 528 000	59 087 000
Total Equity and Debt	338 299 000	423 777 000	507 664 000	526 893 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−21,42 %	−3,91 %	−1,33 %	5,61 %
Debt-to-Equity Ratio	0	0	0,03	0,05
Operating Profit Margin	−13,79 %	−1,37 %	4,38 %	25,09 %
Current Ratio	4,82	6,15	4,06	3,09
Quick Ratio	9,38	14,42	7,21	4,77
Equity Ratio	0,88	0,92	0,87	0,85
Gross Profit Margin	45,87 %	48,33 %	48,65 %	54,49 %